Literature DB >> 28848200

Snail Enhances Glycolysis in the Epithelial-Mesenchymal Transition Process by Targeting FBP1 in Gastric Cancer.

Jie Yu1, Jing Li2, Yong Chen1, Wenmiao Cao1, Yuanyuan Lu1, Jianqi Yang1, Enmin Xing1.   

Abstract

BACKGROUND: Snail is a key regulator of epithelial-mesenchymal transition (EMT) in cancer. However, the regulatory role and underlying mechanisms of Snail in gastric cancer metabolism are unknown. In this study, we characterized the regulation of aerobic glycolysis by Snail in gastric cancer.
METHODS: The impact of Snail on glucose metabolism was studied in vitro. Combining maximum standardized uptake value (SUVmax), which was obtained preoperatively via a PET/CT scan, with immunohistochemistry staining, we further analyzed the correlation between SUVmax and Snail expression in gastric cancer tissues.
RESULTS: Increased expression of Snail promoted lactate production, glucose utilization, and decreased FBP1 expression at both mRNA and protein level. The expression level of Snail was positively associated with SUVmax in gastric cancer patients (P=0.022). Snail and FBP1 expression were inversely correlated at both mRNA and protein level (P=0.002 and P=0.015 respectively) in gastric cancer tissues. Further studies demonstrated that Snail inhibited the FBP1 gene expression at the transcriptional level. Restoring FBP1 expression reversed the effects of glycolysis and EMT induced by Snail in gastric cancer cells.
CONCLUSIONS: Our results thus reveal that Snail serves as a positive regulator of glucose metabolism through regulation of the FBP1 in gastric cancer. Disrupting the Snail-FBP1 signaling axis may be effective to prevent primary tumor EMT and glycolysis process.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Epithelial-mesenchymal transition; FBP1; Gastric cancer; Glycolysis; Snail

Mesh:

Substances:

Year:  2017        PMID: 28848200     DOI: 10.1159/000480314

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

1.  The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.

Authors:  Yan-Ping Zhang; Kai-Long Liu; Zhan Yang; Bao-Sai Lu; Jin-Chun Qi; Zhen-Wei Han; Yue-Wei Yin; Ming Zhang; De-Min Chen; Xiao-Wei Wang; Wei Li; Hong Xin
Journal:  Cell Cycle       Date:  2019-08-25       Impact factor: 4.534

2.  miR-502-5p affects gastric cancer progression by targeting PD-L1.

Authors:  Wendao You; Xiaoyu Liu; Yang Yu; Chen Chen; Yujia Xiong; Yiting Liu; Yibin Sun; Chenhuan Tan; Hanshuo Zhang; Yadong Wang; Rui Li
Journal:  Cancer Cell Int       Date:  2020-08-15       Impact factor: 5.722

3.  Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma.

Authors:  Gao-Min Liu; Qiao Li; Peng-Fei Zhang; Shun-Li Shen; Wen-Xuan Xie; Bin Chen; Jian Wu; Wen-Jie Hu; Xiao-Yong Huang; Bao-Gang Peng
Journal:  Cell Death Dis       Date:  2018-11-14       Impact factor: 8.469

4.  14-3-3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling.

Authors:  Junjun Li; Hao Xu; Qiangping Wang; Sihua Wang; Nanxiang Xiong
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452

Review 5.  Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.

Authors:  Yuanda Liu; Ze Zhang; Junyang Wang; Chao Chen; Xiaohuan Tang; Jiaming Zhu; Jingjing Liu
Journal:  Onco Targets Ther       Date:  2019-02-13       Impact factor: 4.147

6.  Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.

Authors:  Zhonghua Jiang; Xiaohong Wang; Jing Li; Hongmei Yang; Xin Lin
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

7.  CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer.

Authors:  Zhenyong Tang; Lei Li; Yuntian Tang; Dongyi Xie; Kun Wu; Weiyuan Wei; Qiang Xiao
Journal:  Cancer Sci       Date:  2018-07-10       Impact factor: 6.716

8.  FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.

Authors:  Bo Wang; Ping Fan; Jingyuan Zhao; Heyu Wu; Xin Jin; Heshui Wu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10

Review 9.  Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion.

Authors:  Peter Kreuzaler; Yulia Panina; Joanna Segal; Mariia Yuneva
Journal:  Mol Metab       Date:  2019-10-10       Impact factor: 7.422

10.  Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway.

Authors:  Peixin Dong; Ying Xiong; Yosuke Konno; Kei Ihira; Noriko Kobayashi; Junming Yue; Hidemichi Watari
Journal:  J Exp Clin Cancer Res       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.